MoneyWorks4Me

Gland Pharma informs about analyst meet

16 Nov 2021 Evaluate

Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, Gland Pharma has informed that the Analyst/ Institutional Investor Meetings with the Company held on 15th November 2021 with Pictet Asset Management UK.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1759.60
Dr. Reddys Labs. 1216.30
Cipla 1311.60
Lupin 1957.05
Zydus Lifesciences 1114.10
View more..